[go: up one dir, main page]

FI960888L - Protokadheriiniproteiineja ja niiden käyttö - Google Patents

Protokadheriiniproteiineja ja niiden käyttö Download PDF

Info

Publication number
FI960888L
FI960888L FI960888A FI960888A FI960888L FI 960888 L FI960888 L FI 960888L FI 960888 A FI960888 A FI 960888A FI 960888 A FI960888 A FI 960888A FI 960888 L FI960888 L FI 960888L
Authority
FI
Finland
Prior art keywords
protocadherin
proteins
protocadherin proteins
Prior art date
Application number
FI960888A
Other languages
English (en)
Swedish (sv)
Other versions
FI960888A7 (fi
FI960888A0 (fi
Inventor
Shintaro Suzuki
Original Assignee
Doheny Eye Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Doheny Eye Inst filed Critical Doheny Eye Inst
Publication of FI960888A7 publication Critical patent/FI960888A7/fi
Publication of FI960888A0 publication Critical patent/FI960888A0/fi
Publication of FI960888L publication Critical patent/FI960888L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI960888A 1994-06-27 1995-06-26 Protokadheriiniproteiineja ja niiden käyttö FI960888L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/268,161 US5798224A (en) 1992-12-29 1994-06-27 Nucleic acids encoding protocadherin
PCT/US1995/008071 WO1996000289A1 (en) 1994-06-27 1995-06-26 Protocadherin proteins and their uses

Publications (3)

Publication Number Publication Date
FI960888A7 FI960888A7 (fi) 1996-02-26
FI960888A0 FI960888A0 (fi) 1996-02-26
FI960888L true FI960888L (fi) 1996-02-26

Family

ID=23021746

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960888A FI960888L (fi) 1994-06-27 1995-06-26 Protokadheriiniproteiineja ja niiden käyttö

Country Status (18)

Country Link
US (5) US5798224A (fi)
EP (1) EP0719330B1 (fi)
JP (1) JP3560344B2 (fi)
CN (1) CN1105187C (fi)
AT (1) ATE309347T1 (fi)
AU (1) AU699135B2 (fi)
BR (1) BR9506058A (fi)
CA (1) CA2170156A1 (fi)
CZ (1) CZ288789B6 (fi)
DE (1) DE69534588D1 (fi)
FI (1) FI960888L (fi)
HU (1) HU221637B1 (fi)
MX (1) MX9600666A (fi)
NO (1) NO319686B1 (fi)
PL (1) PL182324B1 (fi)
RU (1) RU2197525C2 (fi)
SK (1) SK281413B6 (fi)
WO (1) WO1996000289A1 (fi)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033551A2 (en) 1996-03-15 1997-09-18 Millennium Pharmaceuticals Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation
JP2001509153A (ja) * 1997-01-09 2001-07-10 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれをコードするポリヌクレオチド
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU3908299A (en) * 1997-12-08 1999-06-28 Ontogeny, Inc. Cadherin-like polypeptides, methods and compositions related thereto
EP2264176A1 (en) * 1997-12-10 2010-12-22 CSL Limited Porphorymonas gingivalis polypeptides and polynucleotides
NZ528694A (en) * 1998-03-26 2005-04-29 Genentech Inc Novel PRO531 polypeptides and nucleic acids encoding same, with homology to protocadherin
US20050203025A1 (en) * 1998-05-05 2005-09-15 Adherex Technologies, Inc. Compounds and methods for modulating nonclassical cadherin-mediated functions
US6472367B1 (en) 1998-05-05 2002-10-29 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin mediated cell adhesion
US6638911B1 (en) 1998-05-05 2003-10-28 Adherex Technologies Inc. Compounds and methods for modulating desmosomal cadherin-mediated functions
US7481999B2 (en) * 1998-05-05 2009-01-27 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin-mediated function
US6680175B2 (en) * 1998-05-05 2004-01-20 Adherex Technologies, Inc. Methods for diagnosing and evaluating cancer
US6277824B1 (en) 1998-07-10 2001-08-21 Adherex Technologies Compounds and methods for modulating adhesion molecule function
US20030096951A1 (en) * 1998-08-14 2003-05-22 Kenneth Jacobs Secreted proteins and polynucleotides encoding them
US7041807B1 (en) 1999-06-23 2006-05-09 Caprion Pharmaceuticals, Inc. Antibodies to a YYX epitope of a mammalian prion protein
US6787136B1 (en) 1999-09-03 2004-09-07 The Brigham And Women's Hospital, Inc. Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
US7193050B2 (en) 2000-02-18 2007-03-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CN1313328A (zh) * 2000-03-15 2001-09-19 上海博德基因开发有限公司 一种新的多肽——人原钙粘素14和编码这种多肽的多核苷酸
WO2001094361A2 (en) * 2000-06-06 2001-12-13 Genaissance Pharmaceuticals, Inc. Haplotypes of the pcdh2 gene
US6790636B1 (en) * 2000-06-14 2004-09-14 The United States Of America As Represented By The Department Of Health And Human Services Rapid fluorescent labeling of tissue for microdissection using fluorescent specific binding agents
CA2410898A1 (en) * 2000-07-19 2002-01-24 Pharmacia & Upjohn Company Substrates and assays for .beta.-secretase activity
US7122311B2 (en) 2001-07-16 2006-10-17 Novartis Ag Methods for determining the risk of developing asthma characterized by bronchial hyperresponsiveness
US20040072236A1 (en) 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
US7476509B2 (en) * 2002-11-14 2009-01-13 Adherex Technologies Inc. Compounds and methods for modulating functions of nonclassical cadherins
US7419953B2 (en) * 2003-05-01 2008-09-02 The Scripps Research Institute Selective R-cadherin antagonist and methods
CN101492673B (zh) * 2008-01-25 2012-01-11 中国科学院上海生命科学研究院 非洲爪蟾xpapc基因启动子及其组织特异性增强子
CN102274506A (zh) * 2008-09-07 2011-12-14 苏州爱生基因有限公司 治疗或预防癌症的药物
CN102274509A (zh) * 2008-09-07 2011-12-14 苏州爱生基因有限公司 治疗或预防癌症的药物
CN102274501A (zh) * 2008-09-07 2011-12-14 苏州爱生基因有限公司 一种治疗或预防癌症的药物
CN102274503A (zh) * 2008-09-07 2011-12-14 苏州爱生基因有限公司 治疗或预防癌症的药物
CN102274499A (zh) * 2008-09-07 2011-12-14 苏州爱生基因有限公司 用于治疗或预防癌症的药物
CN102274490A (zh) * 2008-09-07 2011-12-14 苏州爱生基因有限公司 一种用于治疗或预防癌症的药物
CN102274489A (zh) * 2008-09-07 2011-12-14 苏州爱生基因有限公司 治疗或预防癌症的药物
CN102274507A (zh) * 2008-09-07 2011-12-14 苏州爱生基因有限公司 一种用于治疗或预防癌症的药物
SG10201401604VA (en) * 2009-04-20 2014-08-28 Oxford Biotherapeutics Ltd Antibodies Specific To Cadherin-17
JPWO2011115268A1 (ja) * 2010-03-18 2013-07-04 大日本住友製薬株式会社 腫瘍血管新生阻害剤
US8877188B2 (en) 2010-05-04 2014-11-04 The Brigham And Women's Hospital, Inc. Detection and treatment of non-dermal fibrosis
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
CN103194476A (zh) * 2013-04-07 2013-07-10 新乡医学院 鸡pcdh1基因部分片段的克隆、表达及多克隆抗体的制备
BR112017001588A2 (pt) * 2014-08-12 2017-11-21 Novartis Ag conjugados de anticorpo/fármaco anti-cdh6
US11097005B2 (en) 2014-12-15 2021-08-24 The Brigham And Women's Hospital, Inc. Use of cadherin-11 antagonists to treat metabolic disorders and/or increase insulin sensitivity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0494175A4 (en) * 1989-09-27 1993-05-05 Athena Neurosciences, Inc. Compositions for cell adhesion inhibition and methods of use
DE69129760T2 (de) * 1990-10-30 1999-03-25 La Jolla Cancer Research Foundation, La Jolla, Calif. T-cadherin-bindungsmolekül

Also Published As

Publication number Publication date
CZ48296A3 (en) 1996-11-13
NO960767D0 (no) 1996-02-26
SK25296A3 (en) 1997-02-05
ATE309347T1 (de) 2005-11-15
MX9600666A (es) 1997-06-28
FI960888A7 (fi) 1996-02-26
WO1996000289A1 (en) 1996-01-04
PL182324B1 (pl) 2001-12-31
CA2170156A1 (en) 1996-01-04
NO960767L (no) 1996-04-26
DE69534588D1 (de) 2005-12-15
CZ288789B6 (cs) 2001-09-12
CN1105187C (zh) 2003-04-09
EP0719330A1 (en) 1996-07-03
HU9600449D0 (en) 1996-04-29
SK281413B6 (sk) 2001-03-12
FI960888A0 (fi) 1996-02-26
HUT75825A (en) 1997-05-28
AU699135B2 (en) 1998-11-26
JPH09505740A (ja) 1997-06-10
RU2197525C2 (ru) 2003-01-27
CN1134172A (zh) 1996-10-23
US5708143A (en) 1998-01-13
JP3560344B2 (ja) 2004-09-02
US5798224A (en) 1998-08-25
AU2872495A (en) 1996-01-19
US20030139581A1 (en) 2003-07-24
EP0719330B1 (en) 2005-11-09
PL313256A1 (en) 1996-06-24
NO319686B1 (no) 2005-09-05
BR9506058A (pt) 1997-08-05
US5891706A (en) 1999-04-06
US6262237B1 (en) 2001-07-17
HU221637B1 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
FI960888L (fi) Protokadheriiniproteiineja ja niiden käyttö
EE9700209A (et) Dihüdropürimidiinid ja nende kasutamine
FI964334A7 (fi) Polymeroitava koostumus ja sen käyttö
FI953479A7 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
FI945625A7 (fi) Indolokarbatsoli-imidit ja niiden käyttö
FI962879L (fi) Sinkkisormiproteiinijohdannaisia ja niiden menetelmiä
FI942333A0 (fi) Silyylillä silloitetut metalloseenit ja niiden käyttö
FI942682L (fi) Bisfluorenyylimetalloseenit ja niiden käyttö
EE03427B1 (et) Pihusti sõlm ja selle kasutamine
FI961599A7 (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
FI951801A7 (fi) CTLA4-molekyylit ja IL4:sitovat molekyylit sekä näiden käyttö
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
BR9610109A (pt) Fecho e uso mesmo
FI972245A0 (fi) Meso-monojodisubstituoidut tetramakrosykliset yhdisteet sekä niiden valmistus- ja käyttömenetelmät
FI962692L (fi) Kosketusherkkä näyttö ja päätelaite
FI951101L (fi) 5-vinyyli- ja 5-etinyylikinoloni- ja -naftyridonikarboksyylihapot
FI943734A7 (fi) Uudet makrolidit ja niiden käyttö
FI964267A7 (fi) Porfosyaniini ja CNC-laajennetut porfyriinit
ID19147A (id) Ksilanase dan pemakaiannya
BR9509688A (pt) Composto e composição farmacêutica
FI972551L (fi) Päällystyslaite ja menetelmä sitä varten
FI962836L (fi) Psoriasiksen vastaisia peptidejä ja menetelmiä
FI964446L (fi) Uusia tetrapeptidejä, niiden valmistus ja käyttö
KR960010685A (ko) 펩티드 및 그 용도
FI965172L (fi) Uusia amido-kinoksaliinidioneja, niiden valmistus ja käyttö

Legal Events

Date Code Title Description
MA Patent expired